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We report a case of a 61-year-old patient presenting with cardiogenic shock. His echocardiogram suggested typical features of
cardiac amyloidosis.This case demonstrates that cardiac amyloidosiscan present acutely and may be catastrophic.
1.CaseReport
A 61-year-old Iranian male, nondiabetic, and nonhyperten-
sive, presented with sudden onset syncope. He had history
of exertional dyspnea for two months, being investigated
in private clinics. On arrival, he was profusely sweating,
afebrile with cold clammy peripheries. Clinically, he was
in shock with blood pressure of 55/30mmHg and pulse
110 beats per minute. His complete blood count was
normal, but serum creatinine was 449mmol/L with urea
25mmol/L. His Troponin T was 0.9µg/L and N-terminal
pro-B-type natriuretic peptide (BNP) was 978pg/mL. His
ECG showed sinus rhythm with low voltage complexes with-
outischemic changes. Bedsidetransthoracic echocardiogram
done showed nondilated ventricles with good biventricular
function, butthere was severe concentric left ventricular wall
thickening with “sparkling” appearance, mitral valve leaﬂet
and interatrial septal thickening, biatrial enlargement, and
mild circumferential pericardial eﬀusion(Figure 1).Allthese
features were typical of cardiac amyloidosis. Doppler mitral
inﬂow showed restrictive pattern. Tissue Doppler imaging of
mitral annulus (MA) showed decreased systolic longitudinal
velocity (S) (septal MA 4.1cm/s, lateral MA 5.3cm/s) and
decreased early diastolic longitudinal velocity (E)( s e p t a l
MA 4.96cm/s and lateral 4.29cm/s) with E/E ratio of 13
(Figure 2).He wastreated withintravenousﬂuids, inotropes,
butwithinfewhours,hewentintopulselesselectricalactivity
and expired.
2.Discussion
Cardiac amyloidosis is commonlyseen in systemic (primary)
AL amyloidosis and senile systemic amyloidosis. In 90%
of AL patients, heart is aﬀected pathologically, and in
50% of whom, diastolic dysfunction with physical signs
of right heart failure is a presenting feature. Conversely,
<5% of patients with AL amyloidosis involving the heart
have clinically isolated cardiac disease, but most frequently
they have features of multiorgan dysfunction [1]. This was
seen in our patient who primarily presented with cardiac
amyloidosis but also had renal impairment. In a study,
median age at presentation was 59 years (range 29–85), and
AL cardiac disease was unusual both in patients under the
age of 40 (3.0%) and in non-Caucasians (6.5%) [1]. Case-
control studies indicate that echocardiographic evidence
of left ventricular wall thickening, biatrial enlargement,
and increased echogenicity in conjunction with reduced
electrocardiographic voltagesisstronglysuggestiveofcardiac
amyloidosis [2]. Myonecrosis and small-vessel ischemia due
to amyloid deposit cause an increase in cardiac troponins
[3], whereas diastolic dysfunction and increased genetic
expression of natriuretic peptide genes in the amyloid
inﬁltrated ventricles cause increase in plasma BNP levels [4].
The diagnosis of AL amyloidosis requires demonstration of
amyloid in tissue (eitherby ﬁne-needle aspiration ofabdom-
inal fat or rectum or organ biopsy) and demonstration of a
plasma cell dyscrasia (eitherbybonemarrow biopsyshowing
predominance of Kappa or Lambda light chain producing2 Cardiology Research and Practice
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Figure 1: Transthoracic echocardiography in apical 4-chamber view (a) and parasternal view (b), demonstrating a small left ventricle with
severe concentric left ventricular wall thickening with “sparkling” appearance, mitral valve leaﬂet and interatrial septal thickening, biatrial
enlargement, and mild circumferential pericardial eﬀusion in patient with cardiac amyloidosis.
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Figure 2: Transthoracic echocardiography in short-axis view (a) demonstrating severe concentric left ventricular wall thickening with
“sparkling” appearance in a patient with cardiac amyloidosis. Tissue Doppler imaging (b) illustrating reduced systolic and early diastolic
velocities at septal mitral annulus in a patient with cardiac amyloidosis.
plasma cellsorbythe presenceofamonoclonal Iglight chain
inthe serumor urine electrophoresis and/orelevated serum-
free light chain by immunoassay). These tests could not be
done in this patient as he had a rapid downhill course. The
prognosisisusuallypoor,withamediansurvival of8months
after the onset of heart failure [1], speciﬁcally in patients
withraised troponins and BNPlevels[2]. The exact cause for
cardiogenicshockinthispatientwithpreservedbiventricular
systolic function is not known. Amyloid inﬁltration of heart
aﬀects contractility, electric conduction, and coronary ﬂow
[5]. Systolic dysfunction occurs when amyloid ﬁbrils involve
more than 25% of the myocardium. Atrial dysfunction
is due to inadequate atrial emptying secondary to loss
of atrial systolic function and increased after load, even
in the presence of sinus electric activity. The extensive
deposition in atrial walls results in atrial standstill or
atrial electromechanical dissociation [5]. Sudden death can
occur due to ventricular tachyarrhythmias, atrioventricular
block, and acute electromechanical dissociation. Autonomic
nervous system involvement by AL amyloidosis can lead to
orthostatic hypotension and syncope. All these factors may
be involved in this patient leading to cardiogenic shock. It
is reported that, in AL amyloidosis, chemotherapy and stem
cell transplantation may arrest and even reverse the disease,
with resultant stabilization or improvement of symptoms
[2]. Thus, early diagnosis is critical in these patients as newer
treatment options can prevent serious complications and
death which was evident in our patient.Cardiology Research and Practice 3
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